InvestorsHub Logo
Followers 10
Posts 468
Boards Moderated 0
Alias Born 08/02/2012

Re: LongRun8 post# 1946

Wednesday, 07/30/2014 12:35:22 PM

Wednesday, July 30, 2014 12:35:22 PM

Post# of 8443
Meant to post this a couple of days ago when I read it initially. But the point is that Medimmune's Synagis may be losing market share. This opens the door even more for NVAX. Or maybe it makes AZN/Medimmune think more about proposing a buyout of NVAX down the road when more Ph2 data comes out (as well as Ph3).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News